NASDAQ · ACB
Aurora Cannabis financials
$4.03−1.47%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 Mar 31 | Q4 '25 Mar 31 | Q4 '24 Mar 31 | Q4 '23 Mar 31 | Q4 '22 Jun 30 | Q4 '21 Jun 30 | Q4 '20 Jun 30 | Q4 '19 Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — | — | — |
| Diluted shares | 56.7M | 54.8M | 43.2M | 32.3M | 21.5M | 16.9M | 9.7M | 8.0M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $46.5M | $95.8M | $100.6M | $173.7M | $340.1M | $340.0M |
| Short-term investments | $37.6M | $0.00 | $3.0M | $0.00 | $1.0M | $3.0M |
| Total debt | $0.00 | $42.9M | $42.3M | $131.8M | $175.9M | $264.6M |
| Total assets | $432.3M | $592.5M | $620.2M | $684.8M | $842.3M | $2.10B |
| Total liabilities | $64.2M | $169.6M | $175.1M | $299.1M | $327.8M | $457.5M |
| Shareholders' equity | $368.1M | $422.9M | $445.1M | $385.7M | $514.5M | $1.64B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology